Trial Profile
A Phase 3 Study to Investigate the Efficacy and Safety of SYR-322 When Used in Combination With Insulin Preparation in Subjects With Type 2 Diabetes in Japan
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 May 2016
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Takeda
- 14 May 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 04 Feb 2012 New trial record